Reduce Your Dose and Increase Injection Frequency
Your total testosterone of 904 ng/dL exceeds the target mid-normal range (400-700 ng/dL), and you should reduce your dose to 50-100 mg weekly instead of 100 mg every 2 weeks to achieve more stable levels and reduce the risk of adverse effects, particularly erythrocytosis. 1, 2
Why Your Current Regimen Needs Adjustment
Your current dosing of 100 mg every 2 weeks creates problematic testosterone fluctuations. The Endocrine Society guidelines explicitly state that for injectable testosterone cypionate, levels should be measured midway between injections, and if testosterone is >700 ng/dL, you must adjust dose or frequency 1. Your level of 904 ng/dL significantly exceeds this threshold.
The pharmacokinetics of testosterone cypionate show that 200 mg injections (your equivalent biweekly dose) cause a threefold rise in serum testosterone peaking at days 2-5, with many men achieving supraphysiologic concentrations, followed by decline to baseline by days 13-14 3. This creates a roller-coaster effect that increases adverse event risk.
Specific Dosing Recommendation
Switch to 50-75 mg intramuscular weekly (or 100 mg weekly if symptoms require). Here's why:
- More stable levels: Weekly injections maintain testosterone in the mid-normal range without the peaks and troughs of biweekly dosing 4
- Lower erythrocytosis risk: Men receiving 100 mg weekly had significantly lower rates of hematocrit >54% compared to 200 mg biweekly (1% vs 8%, p=0.023) 5
- Better physiologic mimicry: Smaller, more frequent doses better replicate normal diurnal patterns 4
The FDA label confirms that 50-400 mg every 2-4 weeks is the approved range, but emphasizes dosing should be adjusted according to patient response 6. Your response indicates you're getting too much testosterone with the current regimen.
Critical Safety Monitoring Required
Check your hematocrit immediately if you haven't had it measured in the last 3 months. The guidelines mandate:
- Hematocrit monitoring at 3-6 months, then annually 1, 2
- If hematocrit >54%, stop therapy immediately until it decreases, evaluate for sleep apnea/hypoxia, then restart at reduced dose 1, 2
- Testosterone therapy causes dose-dependent increases in hemoglobin, with greater increases in older men 1
Your elevated testosterone level puts you at higher risk for erythrocytosis, which increases cardiovascular morbidity and mortality risk.
Target Testosterone Levels
Aim for mid-normal range: 450-600 ng/dL 1, 2, 7. Your current level of 904 ng/dL is 50% above the upper target. The 2018 Endocrine Society guideline specifically states for injectable testosterone cypionate: if mid-interval testosterone is >600 ng/dL, adjust dose or frequency 2.
Free Testosterone Context
Your free testosterone of 38.6 pg/mL appears low-normal (reference range approximately 66-309 pg/mL for adult men, 120-368 pg/mL for men 19-39 years) 8. However, total testosterone drives dosing decisions for injectable testosterone cypionate per guidelines 1, 2. The elevated total testosterone with relatively modest free testosterone suggests you may have elevated SHBG, but this doesn't justify maintaining supraphysiologic total testosterone levels.
Implementation Algorithm
- Immediate: Check hematocrit, PSA (if age ≥40), and assess for symptoms of polycythemia
- Week 1: Switch to 50 mg IM weekly (or 75 mg if you have persistent hypogonadal symptoms)
- Month 3-6: Recheck testosterone level midway between injections (day 3-4 after injection)
- Adjust: If testosterone <400 ng/dL, increase to 75-100 mg weekly; if >700 ng/dL, reduce to 40-50 mg weekly
Common Pitfall to Avoid
Don't assume that because your free testosterone seems modest, you need to maintain the high total testosterone. The guidelines are clear: therapy should aim to raise serum testosterone into the mid-normal range 1, 2, not to maximize levels. Supraphysiologic dosing increases risks (erythrocytosis, cardiovascular events, mood fluctuations) without proportional benefits 3, 9.